Trials / Completed
CompletedNCT00531713
Effect of T4-T3 Combination Therapy Versus T4 Monotherapy in Patients With Hypothyroidism
Effect of T4-T3 Combination Therapy Versus T4 Monotherapy in Patients With Hypothyroidism,a Double Blind Randomized Cross-Over Study.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 59 (actual)
- Sponsor
- Copenhagen University Hospital at Herlev · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To compare the effect of T4-T3 combination therapy versus T4 monotherapy in patients with autoimmune hypothyroidism, on stable T4-substitution therapy
Detailed description
double blind randomized cross-over study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Triiodothyronine | 50 microgram of the usual T4 is withdrawn and the patients is given 20 microgram of T3 |
Timeline
- Start date
- 2003-04-01
- Completion
- 2007-03-01
- First posted
- 2007-09-19
- Last updated
- 2007-09-19
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00531713. Inclusion in this directory is not an endorsement.